AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 6336983
Drug: Intrapleural administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrapleural administration of 500 mg of tetracycline in solution (pH = 2.8)
Trial: 6336983
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (solution of similar pH and appearance)
Trial: 21532737
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose intravenous methylprednisolone (1 g) followed by oral prednisolone
Trial: 7575052
Drug: Oral prednisolone
RxNorm normalized name: prednisolone Oral Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral prednisolone alone
Trial: 21532737
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups (methylprednisolone + oral prednisolone and oral prednisolone alone)
Trial: 16253403
Drug: Multi-fibre-enriched formula
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multi-fibre-enriched formula (15 g/l)
Trial: 9495662
Drug: Captopril-based treatment
RxNorm normalized name: Captopril
DrugBank: Captopril (DB01197)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Captopril-based treatment
Trial: 9495662
Drug: Conventional antihypertensive
RxNorm normalized name: ANTIHYPERTENSIVES
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional antihypertensive therapy (diuretics and/or beta-blockers)
Trial: 2939666
Drug: Inactivated influenza
RxNorm normalized name: influenza, inactivated, whole virus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inactivated influenza vaccine (A (H3N2) + A (H1N1), 3.0‐3.4 micrograms of hemagglutinin per 0.2 ml)
Trial: 31133099
Drug: Vitamin D
RxNorm normalized name: Vitamin D
DrugBank: Vitamin D (DB11094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D supplementation (700 U) and 100 mg of calcium
Trial: 31133099
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (100 U of Vitamin D and 100 mg of calcium)
Trial: 19947273
Drug: Tuina treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tuina treatment on ten points using thumb and middle finger
Trial: 19947273
Drug: Medication group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication group (oral Chlorpheniramine and topical zinc oxide ointment or Youzhuoer ointment)
Trial: 16924568
Drug: Nebulized budesonide
RxNorm normalized name: Budesonide
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Nebulized budesonide (NB) 4 mg/day
Trial: 16924568
Drug: Systemic corticosteroid
RxNorm normalized name: CORTICOSTEROIDS FOR SYSTEMIC USE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Systemic corticosteroid (SC) 1 mg/kg/day methylprednisolone
Trial: 9075036
Drug: High thoracic
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High thoracic epidural anesthesia (HTE) with 2% lidocaine 5 ml
Trial: 17566093
Drug: Flutamide 125
RxNorm normalized name: flutamide 125 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flutamide 125 mg
Trial: 17566093
Drug: Flutamide 250
RxNorm normalized name: flutamide 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flutamide 250 mg
Trial: 17566093
Drug: Flutamide 375
RxNorm normalized name: Flutamide
DrugBank: Flutamide (DB00499)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Flutamide 375 mg
Trial: 8503338
Drug: Flutamide 750
RxNorm normalized name: Flutamide
DrugBank: Flutamide (DB00499)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Flutamide 750 mg
Trial: 8503338
Drug: Flutamide 1125
RxNorm normalized name: Flutamide
DrugBank: Flutamide (DB00499)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Flutamide 1125 mg
Trial: 8503338
Drug: Flutamide 1500
RxNorm normalized name: Flutamide
DrugBank: Flutamide (DB00499)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Flutamide 1500 mg
Trial: 8503338
Drug: Flutamide 1500
RxNorm normalized name: Flutamide
DrugBank: Flutamide (DB00499)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Flutamide 1500 mg/day
Trial: 8503338
Drug: Flutamide (various
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flutamide (various doses)
Trial: 3100110
Drug: 4 IU
RxNorm normalized name: Cholecalciferol/Vitamin E 14000 IU-34 IU Oral Wafer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 IU hGH, subcutaneously, 12-hourly for 72 hours before GHRH test
Trial: 3100110
Drug: 4 IU
RxNorm normalized name: Cholecalciferol/Vitamin E 14000 IU-34 IU Oral Wafer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 IU hGH, single subcutaneous dose, 12 hours before GHRH test
Trial: 3100110
Drug: Placebo, subcutaneously,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo, subcutaneously, 12-hourly for 72 hours before GHRH test
Trial: 27637735
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (received treatment after crossover)
Trial: 29408304
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of automated plus live prompts
Trial: 16483391
Drug: Low-dose, high-concentration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dose, high-concentration localized botulinum toxin A (BTX-A) injections (total dose 82-220 units, mean 139 [SD 37.48]; dilution 100 units/0.5ml)
Trial: 16483391
Drug: Low-dose, high-concentration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dose, high-concentration localized botulinum toxin A (BTX-A) injections
Trial: 4027872
Drug: PALA alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PALA alone (800 to 1000 mg/m2 per day for 5 days every 2 weeks)
Trial: 4027872
Drug: PALA +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PALA + 5-FU (PALA: 400 mg/m2 per day for 5 days, 5-FU: 300 mg/m2 per day for 5 days every 28 days)
Trial: 4027872
Drug: 5-FU alone
RxNorm normalized name: 5-FU
DrugBank: Fluorouracil (DB00544)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 5-FU alone (300 to 400 mg/m2 per day for 5 days every 21 days)
Trial: 30513988
Drug: Juçara supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Juçara supplementation (5 g juçara freeze-dried pulp)
Trial: 27263403
Drug: Maternal Hb
RxNorm normalized name: Citalopram Hydrobromide
DrugBank: Citalopram (DB00215)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Maternal Hb concentration ≤109 g/L during 24-28 weeks of gestation
Trial: 27263403
Drug: Maternal Hb
RxNorm normalized name: Citalopram Hydrobromide
DrugBank: Citalopram (DB00215)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Maternal Hb concentration 120-129 g/L during 24-28 weeks of gestation
Trial: 27263403
Drug: Maternal Hb
RxNorm normalized name: Citalopram Hydrobromide
DrugBank: Citalopram (DB00215)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Maternal Hb concentration ≥130 g/L during 24-28 weeks of gestation
Trial: 22723003
Drug: AC+CC genotype
RxNorm normalized name: dengue virus live antigen, CYD serotype 1 / dengue virus live antigen, CYD serotype 2 / dengue virus live antigen, CYD serotype 3 / dengue virus live antigen, CYD serotype 4 Injection [Dengvaxia]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AC+CC genotype
Trial: 14560861
Drug: Tramadol 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramadol 1.5 mg/kg
Trial: 10232312
Drug: co‐trimoxazole (800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: co‐trimoxazole (800 mg/160 mg)
Trial: 1987739
Drug: Intracavitary brachytherapy
RxNorm normalized name: carmustine
DrugBank: Carmustine (DB00262)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intracavitary brachytherapy boost (10-15 Gy) following external beam radiation therapy (60-64 Gy).
Trial: 1987739
Drug: External beam
RxNorm normalized name: Beam
DrugBank: Tricyclazole (DB02891)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: External beam radiation therapy alone (65-70 Gy).
Trial: 6132178
Drug: Meptazinol, 300-500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meptazinol, 300-500 mg intravenously
Trial: 6132178
Drug: Naloxone, 30-40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naloxone, 30-40 mg intravenously
Trial: 29353631
Drug: Sodium bicarbonate
RxNorm normalized name: Sodium Bicarbonate
DrugBank: Sodium bicarbonate (DB01390)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium bicarbonate 5% aqueous solution (double dose)
Trial: 22938716
Drug: Budesonide 400
RxNorm normalized name: Budesonide 400 microgram/actuation powder for inhalation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide 400 μg daily
Trial: 22938716
Drug: Nedocromil 16
RxNorm normalized name: NEDOCROMIL
DrugBank: Nedocromil (DB00716)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nedocromil 16 mg daily
Trial: 22938716
Drug: Inhaled glucocorticoids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled glucocorticoids (higher doses in first 2 years)
Trial: 12784695
Drug: Evidence-based medicine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Evidence-based medicine (EBM) practices in stroke management
Trial: 9849415
Drug: Non-oral contraceptive
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-oral contraceptive users
Trial: 2152803
Drug: 0.5 mg
RxNorm normalized name: biotin 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg oral solution
Trial: 2152803
Drug: 0.5 mg
RxNorm normalized name: biotin 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg tablet
Trial: 7855966
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg tablet
Trial: 2152803
Drug: 0.5 mg
RxNorm normalized name: biotin 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg intravenous infusion
Trial: 2152803
Drug: All oral
RxNorm normalized name: Exall Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: All oral doses
Trial: 380912
Drug: Levamisole (2.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levamisole (2.0 to 2.5 mg per kg body weight, single dose on 1 day per week for 4 months)
Trial: 27977473
Drug: Bremelanotide 1.75
RxNorm normalized name: BREMELANOTIDE 1.75MG/0.3ML AUTOINJECTOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bremelanotide 1.75 mg
Trial: 31658134
Drug: Nicorandil therapy
RxNorm normalized name: nicorandil
DrugBank: Nicorandil (DB09220)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicorandil therapy (nicorandil 10 mg three times daily plus hydration)
Trial: 31658134
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment (hydration only)
Trial: 31658134
Drug: Nicorandil therapy
RxNorm normalized name: nicorandil
DrugBank: Nicorandil (DB09220)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicorandil therapy
Trial: 19407444
Drug: aspirin (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: aspirin (100 mg/day)
Trial: 28062625
Drug: High-sensitivity troponin
RxNorm normalized name: Fluorimax Sensitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-sensitivity troponin I (hs-TnI) >26 ng/L
Trial: 28062625
Drug: High-sensitivity troponin
RxNorm normalized name: Fluorimax Sensitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-sensitivity troponin I (hs-TnI) <1.9 ng/L
Trial: 28062625
Drug: Vorapaxar in
RxNorm normalized name: Product containing vorapaxar in oral dose form (medicinal product form)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vorapaxar in patients with hs-TnI >26 ng/L
Trial: 28062625
Drug: Vorapaxar in
RxNorm normalized name: Product containing vorapaxar in oral dose form (medicinal product form)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vorapaxar in patients with hs-TnI <1.9 ng/L
Trial: 26440235
Drug: Propofol at
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol at a rate of 120 mcg/kg/min starting immediately after CPB and maintained throughout surgery and for 6 hours in ICU
Trial: 26440235
Drug: Propofol at
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol at a dose of 30-50 mcg/kg/min starting at chest closure and continued for 6 hours in ICU
Trial: 15906019
Drug: Tramadol-HCl 100
RxNorm normalized name: Tramadol Hydrochloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramadol-HCl 100 mg
Trial: 15906019
Drug: Tramadol-HCl 150
RxNorm normalized name: tramadol hydrochloride 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramadol-HCl 150 mg
Trial: 15906019
Drug: Tramadol-HCl 50
RxNorm normalized name: tramadol hydrochloride 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramadol-HCl 50 mg
Trial: 12270852
Drug: Sitaxsentan (selective
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sitaxsentan (selective ET(A) receptor antagonist) infused at increasing rates (0.3125 to 10 mg/min) in patients with HF
Trial: 12270852
Drug: Sitaxsentan (selective
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sitaxsentan (selective ET(A) receptor antagonist) infused in control subjects
Trial: 9638665
Drug: Various chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Various chemotherapy protocols (SIOP 1, SIOP 2, HDMTX/VCR, HIT protocol 89/91, Carbo-PEI)
Trial: 9638665
Drug: HIT protocol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HIT protocol 89/91 as first-line treatment
Trial: 9638665
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment (surgery and radiotherapy alone)
Trial: 27447160
Drug: Test implant
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test implant system
Trial: 27447160
Drug: Predicate implant
RxNorm normalized name: ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Predicate implant system
Trial: 25197812
Drug: Intravenous bolus
RxNorm normalized name: SET,INFUSION,BOLUS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous bolus of normal saline (22 mL/kg body weight) after sleep onset with compression stockings to prevent fluid accumulation in the legs.
Trial: 25197812
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline infusion to keep the vein open (control arm).
Trial: 20961386
Drug: 1% chlorhexidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% chlorhexidine gel (CHX-Gel)
Trial: 20961386
Drug: 0.12% chlorhexidine
RxNorm normalized name: CHLORHEXIDINE GLUCONATE 1.2 [iU] in 1 mL BUCCAL MOUTHWASH [0.12% Chlorhexidine Gluconate Oral Rinse]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.12% chlorhexidine dentifrice-gel (CHX-DFG)
Trial: 20961386
Drug: 1% CHX-Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% CHX-Gel and 0.2% CHX-MW
Trial: 18381138
Drug: Statin use,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Statin use, beta-blockers, antiplatelet drugs
Trial: 9140517
Drug: Specific immunotherapy
RxNorm normalized name: Pacific halibut
DrugBank: Pacific halibut (DB10616)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Specific immunotherapy with standardized extracts of Dermatophagoides pteronyssinus and D. farinae
Trial: 2884454
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg 33B3.1 daily by intravenous infusion for 14 days (group A)
Trial: 2884454
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg 33B3.1 daily by intravenous infusion for 14 days (group B)
Trial: 31707498
Drug: Clobetasol lotion
RxNorm normalized name: clobetasol Topical Lotion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clobetasol lotion
Trial: 29616028
Drug: Direct-acting antiviral
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Direct-acting antiviral (DAA) drug therapies
Trial: 29616028
Drug: HCV clearance
RxNorm normalized name: HCV-086
DrugBank: HCV-086 (DB05884)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HCV clearance by DAA drug therapy
Trial: 25285994
Drug: Oral supplement
RxNorm normalized name: Healios Oral Supplement Unflavored
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral supplement containing Phyllanthus emblica (100 mg), vitamin E (10 mg), and carotenoids (4.7 mg) three times/day for 6 months
Trial: 18457936
Drug: Amoxicillin three-times-daily
RxNorm normalized name: bupropion
DrugBank: Bupropion (DB01156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amoxicillin three-times-daily (TD)
Trial: 18457936
Drug: Roxithromycin once-daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Roxithromycin once-daily (OD)
Trial: 18457936
Drug: Placebo once-daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo once-daily (OD)
Trial: 18457936
Drug: Placebo three-times-daily
RxNorm normalized name: bupropion
DrugBank: Bupropion (DB01156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Placebo three-times-daily (TD)
Trial: 29633652
Drug: Music Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Music Therapy Group (MTG) - 10 individual sessions of music therapy (30-40 minutes each) with a trained music therapist.
Trial: 29633652
Drug: Control Group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control Group (CG) - standard care without music therapy.
Trial: 25285887
Drug: Tat1-86 (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tat1-86 (25 μg)
Trial: 19694216
Drug: Simvastatin (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin (40 mg/d) for 3 months
Trial: 16796606
Drug: Insulin infusion
RxNorm normalized name: iLet Insulin Infusion 10-Pack Kit Inset
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin infusion (steady-state concentration of 100 mU L(-1))
Trial: 9227168
Drug: Corticosteroid (triamcinolone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroid (triamcinolone acetonide, TA) injection
Trial: 9227168
Drug: Yttrium-90 plus
RxNorm normalized name: yttrium
DrugBank: Yttrium Y-90 (DB13076)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yttrium-90 plus corticosteroid (TA+Y) injection
Trial: 26135351
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg crystalline vitamin B‐12 daily for 12 months
Trial: 20032798
Drug: Ospemifene 30
RxNorm normalized name: Ospemifene
DrugBank: Ospemifene (DB04938)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Ospemifene 30 mg/day
Trial: 20962160
Drug: Iron-fortified biscuits
RxNorm normalized name: INFANT FORMULA SMA IRON FORTIFIED CONC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron-fortified biscuits (20 mg Fe/d, 4 times/week)
Trial: 18785059
Drug: CHO‐E solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CHO‐E solution (6% carbohydrate, 50 mg Na/500 ml)
Trial: 16598386
Drug: Topical metronidazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical metronidazole (Noritate 1% Cream, MetroCream 0.75% Cream, MetroLotion 0.75% Lotion, Metrogel 0.75% and 1% Topical Gel)
Trial: 10671842
Drug: Conventional syringe
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional syringe and 25 G needle
Trial: 9323734
Drug: Acuvue lenses
RxNorm normalized name: miconazole
DrugBank: Miconazole (DB01110)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Acuvue lenses with UV blocker
Trial: 9323734
Drug: Conventional Acuvue
RxNorm normalized name: Acuvue Theravision
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional Acuvue lenses without UV blocker
Trial: 3094139
Drug: Imipenem/cilastatin 500/500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imipenem/cilastatin 500/500 mg q6h (77 patients, 56 evaluable for efficacy)
Trial: 3094139
Drug: Gentamicin 1.5
RxNorm normalized name: HYDROCORTISONE ACEPONATE 1.11 mg in 1 mL / MICONAZOLE NITRATE 17.4 mg in 1 mL / GENTAMICIN 1.5 mg in 1 mL AURICULAR (OTIC) SUSPENSION [EASOTIC]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gentamicin 1.5 mg/kg plus clindamycin 600 mg q6h (86 patients, 62 evaluable for efficacy)
Trial: 30508538
Drug: Sublingual high-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual high-dose liquid birch pollen extract (40,000 AUN/mL)
Trial: 18839644
Drug: Oral thiocolchicoside
RxNorm normalized name: thiocolchicoside
DrugBank: Thiocolchicoside (DB11582)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral thiocolchicoside (TC) for one week
Trial: 18839644
Drug: Adrenergic alpha
RxNorm normalized name: alpha tocopherol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adrenergic alpha 2 agonist tizanidine (TZ) for one week
Trial: 15295717
Drug: Candesartan 16
RxNorm normalized name: candesartan 16 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Candesartan 16 mg
Trial: 11294048
Drug: Candesartan 16
RxNorm normalized name: candesartan 16 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Candesartan 16 mg and Lisinopril 20 mg (combination treatment)
Trial: 9272261
Drug: Fluoxetine 3
RxNorm normalized name: fluoxetine 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine 3 x 20 mg/day
Trial: 25920634
Drug: Leukocyte-poor (type-4B)
RxNorm normalized name: interferon alfa-3n,human leukocyte derived
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Leukocyte-poor (type-4B) PRP injection
Trial: 10211492
Drug: Bupivacaine injection
RxNorm normalized name: bupivacaine Injection
DrugBank: Bupivacaine (DB00297)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bupivacaine injection
Trial: 19684043
Drug: Corifollitropin alfa
RxNorm normalized name: corifollitropin alfa
DrugBank: Corifollitropin alfa (DB09066)
FDA approved: no
EMA approved: yes
PMDA approved: no
Description: Corifollitropin alfa (150 microg single injection)